このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Ai Chi-Based Rehabilitation for Peripheral Unilateral Vestibular Dysfunction (AICHI-VR)

2026年5月4日 更新者:Yaren Çelik、Gaziosmanpasa Research and Education Hospital

Contribution of an Ai Chi-Based Rehabilitation Program in Patients With Peripheral Unilateral Vestibular Dysfunction: A Randomized Prospective Single-Blind Study

This study aims to evaluate the effects of an Ai Chi-based rehabilitation program on balance, dizziness severity, and quality of life in patients with unilateral peripheral vestibular hypofunction. Participants will be randomly assigned to either a control group receiving standard home-based vestibular rehabilitation exercises or an intervention group receiving additional Ai Chi sessions. The intervention will be conducted over a 4-week period with a total of 10 sessions under the supervision of a certified therapist.

調査の概要

詳細な説明

Unilateral peripheral vestibular hypofunction is a clinical condition characterized by reduced vestibular function due to inner ear or vestibular nerve pathology. It presents with symptoms such as dizziness, imbalance, visual instability, and impaired postural control, significantly affecting functional independence and quality of life. Diagnosis is typically established by the otorhinolaryngology clinic and supported by vestibular function tests such as videonystagmography (VNG) and video head impulse testing (vHIT).

Vestibular rehabilitation is an evidence-based therapeutic approach aimed at promoting central compensation through mechanisms of adaptation, substitution, and habituation. These mechanisms contribute to the improvement of vestibulo-ocular reflex function, postural stability, and overall functional performance.

Ai Chi is an aquatic exercise program derived from Tai Chi and Qi Gong principles, consisting of slow, continuous, and controlled movements coordinated with breathing. The aquatic environment provides unique therapeutic properties such as buoyancy, hydrostatic pressure, and viscosity, allowing safe movement, reducing fall risk, and enhancing proprioceptive and sensory input. These features may support multisensory integration and facilitate central compensation in patients with vestibular dysfunction.

Although aquatic therapy has been increasingly used in rehabilitation, there is limited evidence regarding the effectiveness of Ai Chi specifically in patients with unilateral peripheral vestibular hypofunction. To the best of our knowledge, no randomized controlled study has specifically evaluated the effects of Ai Chi in this patient population.

In this randomized controlled study, participants will be allocated into two groups. Both groups will receive a standardized home-based vestibular rehabilitation program. In addition, the intervention group will participate in supervised Ai Chi sessions conducted in an aquatic environment over a 4-week period, consisting of a total of 10 sessions. All sessions will be delivered by a certified therapist, and adherence will be monitored using exercise logs.

Assessments will be performed at baseline, immediately after the intervention, and during the follow-up period by a blinded evaluator. The findings of this study are expected to contribute to the development of alternative rehabilitation strategies and provide additional evidence for the management of patients with vestibular disorders.

研究の種類

介入

入学 (推定)

38

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Age between 18 and 70 years
  • Diagnosis of unilateral peripheral vestibular hypofunction
  • Presence of dizziness symptoms for at least 3 months
  • Ability to participate in Ai Chi and aquatic exercise program
  • Berg Balance Scale score ≥21
  • Willingness to participate in the study

Exclusion Criteria:

  • Inability to complete assessment tests and questionnaires
  • Severe systemic disease that may interfere with exercise participation
  • Central vestibular disorders
  • Berg Balance Scale score ≤20
  • Severe visual or hearing impairment
  • Initiation or change of psychiatric medication within the last 3 weeks
  • Severe cardiopulmonary disease
  • Contraindications to hydrotherapy, including water phobia, behavioral disorders, dyspnea at rest, incontinence, known chlorine allergy, open wounds, acute systemic illness, epilepsy, tracheostomy, permanent drainage devices, immunodeficiency, or known neurological disorders

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Ai Chi Group
Participants in this group will receive an Ai Chi-based aquatic exercise program in addition to standard home-based vestibular rehabilitation exercises. The Ai Chi program will be applied over 4 weeks with a total of 10 sessions under the supervision of a certified therapist.
Ai Chi-based exercise program is a structured aquatic therapy approach consisting of slow, continuous, and controlled movements combined with breathing techniques. The program will be conducted in a pool environment over 4 weeks, with a total of 10 sessions delivered as group sessions under the supervision of a certified therapist. The exercises are designed to enhance balance, postural control, proprioceptive input, and multisensory integration, thereby supporting central compensation in patients with vestibular dysfunction.
Participants will receive a structured home-based vestibular rehabilitation program including gaze stabilization, head movement, balance, and postural control exercises. The program aims to promote vestibulo-ocular reflex adaptation, improve postural stability, and reduce dizziness-related symptoms. Participants will be instructed to perform the exercises regularly, and adherence will be monitored using exercise logs.
アクティブコンパレータ:Control Group
Participants in this group will receive standard home-based vestibular rehabilitation exercises without additional Ai Chi intervention.
Participants will receive a structured home-based vestibular rehabilitation program including gaze stabilization, head movement, balance, and postural control exercises. The program aims to promote vestibulo-ocular reflex adaptation, improve postural stability, and reduce dizziness-related symptoms. Participants will be instructed to perform the exercises regularly, and adherence will be monitored using exercise logs.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in balance performance assessed by Berg Balance Scale
時間枠:Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in balance performance will be assessed using the Berg Balance Scale (BBS). The BBS consists of 14 items scored from 0 to 4, with a total score ranging from 0 to 56. Higher scores indicate better balance performance. balance performance will be assessed using the Berg Balance Scale in participants receiving Ai Chi-based exercise program in addition to home-based vestibular rehabilitation, compared with participants receiving home-based vestibular rehabilitation alone.
Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in dizziness-related disability will be assessed using the Dizziness Handicap Inventory (DHI). The DHI consists of 25 items with a total score ranging from 0 to 100. Higher scoredizziness-related disability assessed by Dizziness Handicap Inventory
時間枠:Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in dizziness-related disability will be assessed using the Dizziness Handicap Inventory.
Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in dizziness severity assessed by Vertigo Symptom Scale-Short Form
時間枠:Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in vestibular symptoms will be assessed using the Vestibular Symptoms Scale (VSS). The VSS consists of 15 items evaluating the frequency of vestibular symptoms. Each item is scored from 0 to 4, with a total score ranging from 0 to 60. Higher scores indicate more severe symptoms. dizziness severity will be assessed using the Vertigo Symptom Scale-Short Form.
Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in kinesiophobia assessed by Tampa Kinesiophobia Scale
時間枠:Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in kinesiophobia will be assessed using the Tampa Scale for Kinesiophobia (TSK). The TSK consists of 17 items scored from 1 to 4, with total scores ranging from 17 to 68. Higher scores indicate greater fear of movement.
Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in quality of life assessed by Short Form-36
時間枠:Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in quality of life will be assessed using the Short Form-36 Health Survey (SF-36). The SF-36 consists of 8 subscales scored from 0 to 100, with higher scores indicating better health status.
Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in balance confidence assessed by Activities-specific Balance Confidence Scale
時間枠:Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in balance confidence will be assessed using the Activities-specific Balance Confidence Scale (ABC). The ABC includes 16 items scored from 0% to 100%, with higher scores indicating greater balance confidence.
Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in functional mobility assessed by Timed Up and Go Test
時間枠:Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in functional mobility will be assessed using the Timed Up and Go Test (TUG). The time required to stand up, walk 3 meters, turn, and sit down is recorded in seconds. Lower times indicate better performance.
Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in tandem balance performance assessed by tandem stance/walking duration
時間枠:Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in dynamic balance will be assessed using tandem walking performance. The duration or number of steps maintained in tandem stance is recorded. Higher performance indicates better balance.
Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in perceived benefit assessed by Vestibular Rehabilitation Benefit Questionnaire
時間枠:Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment
Change in perceived benefit will be assessed using the Vestibular Rehabilitation Benefit Questionnaire (VRBQ). The questionnaire evaluates symptom severity and quality of life related to vestibular dysfunction. Raw scores are converted to percentage values ranging from 0 to 100. Higher scores indicate greater symptom severity and poorer quality of life.
Baseline, immediately after the 4-week intervention, and 2 months after the end of treatment

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年4月27日

一次修了 (推定)

2026年5月27日

研究の完了 (推定)

2026年7月27日

試験登録日

最初に提出

2026年4月23日

QC基準を満たした最初の提出物

2026年4月23日

最初の投稿 (実際)

2026年4月30日

学習記録の更新

投稿された最後の更新 (実際)

2026年5月7日

QC基準を満たした最後の更新が送信されました

2026年5月4日

最終確認日

2026年4月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する